By Counterforce Health Team in Elfabrio (pegunigalsidase alfa-iwxj) —

How to Get Elfabrio (pegunigalsidase alfa-iwxj) Covered by Aetna (CVS Health) in Texas: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Elfabrio Covered by Aetna (CVS Health) in Texas

Elfabrio (pegunigalsidase alfa-iwxj) requires prior authorization from Aetna (CVS Health) in Texas. To get approved: (1) Confirm Fabry disease diagnosis with enzyme deficiency testing or genetic analysis, (2) Submit complete PA form with clinical documentation through CVS Specialty or Aetna provider portal, (3) If denied, file internal appeal within 180 days, then external review through Texas Department of Insurance if needed. Start with your prescriber gathering diagnostic labs and prior treatment records today.

Table of Contents

Plan Types & Network Requirements

Your Aetna (CVS Health) plan type affects how you access Elfabrio in Texas:

HMO vs PPO vs EPO Coverage

  • Aetna HMO/Aetna Whole Health: Requires PCP referral to specialists; network-only coverage except emergencies
  • Aetna Open Access EPO (Elect Choice): No PCP/referrals needed; network-only coverage with statewide/nationwide access
  • Aetna Select EPO: Requires PCP and referrals; network-only coverage
  • Aetna PPO: No PCP/referrals; covers out-of-network at higher cost
Note: Regardless of plan type, Elfabrio requires prior authorization and typically must be filled through designated specialty pharmacies.

Texas Network Options

Common Aetna networks in Texas include:

  • Elect Choice Open Access EPO: Largest statewide network
  • Savings Plus of Texas: Narrow network, ~9% cheaper premiums
  • Aetna Whole Health: Regional HMOs (Houston, Dallas, Austin, San Antonio)

Verify your exact network name on your ID card and confirm your prescriber and infusion center are in-network using Aetna's provider directory.

Formulary Status & Coverage Rules

Coverage Channel

Elfabrio is covered under medical benefit (not pharmacy benefit) because it's an IV infusion administered every 2 weeks. Claims are billed using HCPCS code J2508 (Injection, pegunigalsidase alfa-iwxj, 1 mg).

Medical Necessity Criteria

Aetna's Lysosomal Storage Disorder policy (CPB 0442) requires:

  • Adult age: ≥18 years at initiation
  • Confirmed Fabry disease by enzyme assay showing α-galactosidase A deficiency OR genetic testing showing GLA mutation OR symptomatic obligate carrier status
  • Specialist prescriber: Geneticist, metabolic specialist, nephrologist, cardiologist, or clinician experienced in Fabry disease
  • No concurrent therapy: Cannot receive other Fabry ERTs or migalastat (Galafold) simultaneously

Prior Authorization Requirements

Required Documentation

Your prescriber must submit:

  1. Diagnostic confirmation:
    • α-Galactosidase A enzyme activity results showing deficiency
    • OR GLA gene testing report with pathogenic/likely pathogenic variant
    • ICD-10 code E75.21 (Fabry-Anderson disease)
  2. Clinical assessment:
    • Current symptoms and organ involvement (kidney, cardiac, neurologic)
    • Baseline labs (eGFR, proteinuria, cardiac function if relevant)
    • Prior Fabry treatments and outcomes
  3. Prescriber information:
    • Specialist credentials and experience with Fabry disease
    • Treatment plan and monitoring schedule

Submission Process

Submit through:

  • CVS Specialty enrollment forms (condition-specific Fabry/enzyme replacement form)
  • Aetna provider portal for medical benefit drugs
  • Fax: Use number on specific PA form (verify current number)

Expected timeline: 30-45 days for standard review; ≤72 hours for expedited/urgent requests.

Step-by-Step: Fastest Path to Approval

1. Gather Diagnostic Evidence

Who: Prescriber
What: Obtain α-Gal A enzyme levels or GLA genetic testing results
Timeline: Order if not available; results typically 1-2 weeks
Source: Aetna genetic testing policy (CPB 0140)

2. Document Clinical Status

Who: Prescriber
What: Record Fabry symptoms, organ involvement, prior treatments
Include: Kidney function, cardiac status, neuropathic pain, quality of life impact
Timeline: Same visit as prescription

3. Submit Complete PA Request

Who: Prescriber or staff
What: CVS Specialty enrollment form with all clinical documentation
How: Fax, ePrescribe to CVS Specialty, or provider portal
Timeline: Submit within 1-2 business days

4. Follow Up on Status

Who: Clinic staff
When: 5-7 business days after submission
How: Call Aetna provider services or check portal for PA status
Action: Provide additional information if requested

5. Set Up Specialty Pharmacy

Who: Patient with CVS Specialty support
What: Complete enrollment, verify insurance, arrange delivery/infusion site
Timeline: Concurrent with PA approval
Details: See Specialty Pharmacy Setup section

Specialty Pharmacy Setup

CVS Specialty Requirements

Most Aetna plans require Elfabrio to be dispensed through CVS Specialty Pharmacy. The setup process includes:

  1. Provider enrollment: Prescriber submits CVS Specialty enrollment form
  2. Patient intake: CVS Specialty calls patient for demographics, insurance verification, and clinical counseling
  3. Benefits investigation: CVS Specialty determines coverage, copay, and available assistance programs
  4. Delivery coordination: Arrange shipping to home or infusion center

Site of Care Options

  • Infusion centers: Most common for Elfabrio administration
  • Hospital outpatient departments: May require additional authorization
  • Home infusion: Available in some areas with nursing support

Verify your preferred site is in-network and approved for Elfabrio administration.

Common Denial Reasons & Solutions

Denial Reason Solution Required Documentation
Lack of confirmed Fabry diagnosis Submit enzyme/genetic testing α-Gal A levels or GLA mutation report
Age requirement not met Verify patient ≥18 years Birth certificate or ID
Non-specialist prescriber Obtain specialist consultation Referral to geneticist, nephrologist, or cardiologist
Concurrent Fabry therapy Discontinue other ERTs/migalastat Medication list showing no concurrent therapy
Insufficient clinical documentation Provide comprehensive assessment Organ function tests, symptom documentation
Site of care restriction Use approved facility Network verification for infusion center
Tip: Counterforce Health helps patients and providers turn insurance denials into successful appeals by analyzing denial letters and crafting evidence-backed rebuttals aligned to payer policies.

Appeals Process in Texas

Internal Appeal (First Level)

  • Deadline: 180 days from denial date
  • Timeline: 30 days for pre-service requests, 60 days for post-service
  • How to file: Written request to Aetna with clinical justification
  • Required: Copy of denial letter, additional medical records, prescriber letter

External Review (Texas Department of Insurance)

If internal appeal is denied:

  • Deadline: 4 months from final internal denial
  • Timeline: 20 days for standard review, 5 days for urgent cases
  • Process: Request IRO form from Aetna; submit to Texas Department of Insurance
  • Cost: Free to patient (insurer pays IRO fees)
  • Binding: IRO decision is final and enforceable

Expedited Appeals

For urgent situations where delay could jeopardize health:

  • Internal expedited: ≤72 hours
  • External expedited: ≤5 days
  • Can be filed concurrently with standard appeals

Texas help line: 1-800-252-3439 (TDI Consumer Help)

Cost-Share & Assistance Programs

Typical Aetna Coverage

  • Medical benefit: Subject to deductible and coinsurance (typically 10-30%)
  • Specialty tier: Higher cost-sharing than standard medications
  • Site of care: Lower cost-sharing for preferred infusion centers

Financial Assistance

  • Manufacturer support: Elfabrio Access Resource Guide includes patient assistance programs
  • Copay cards: May be available for commercial plans (not Medicare/Medicaid)
  • Foundation grants: Various rare disease foundations offer assistance
Note: This is educational information only. Consult with your healthcare provider and insurance plan for specific cost estimates.

When to Escalate

Contact Texas regulators if:

  • Aetna doesn't respond within required timeframes
  • You believe the denial violates Texas insurance law
  • Network adequacy issues prevent access to care

Resources:

For Medicaid denials, request a fair hearing through Texas Health and Human Services.

FAQ

How long does Aetna (CVS Health) PA take in Texas? Standard PA decisions take 30-45 days. Expedited reviews for urgent cases are completed within 72 hours.

What if Elfabrio is non-formulary on my plan? Request a formulary exception with clinical justification showing medical necessity and lack of appropriate alternatives.

Can I request an expedited appeal? Yes, if delays would jeopardize your health. Expedited internal appeals take ≤72 hours; external expedited reviews take ≤5 days.

Does step therapy apply if I've used Elfabrio before? For Medicare Part B, Aetna's step therapy doesn't apply if you've received the drug in the past 365 days.

What happens if my specialist is out-of-network? For HMO/EPO plans, you'll need to find an in-network specialist or request a network exception. PPO plans cover out-of-network care at higher cost.

How do I verify my exact Aetna network in Texas? Check your ID card for the specific network name (e.g., "Elect Choice EPO" or "Aetna Whole Health"). Use Aetna's online provider directory to confirm network participation.

Counterforce Health transforms insurance denials into targeted appeals by analyzing denial letters, plan policies, and clinical notes to craft evidence-backed rebuttals. The platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and turn denials into approvals. Learn more at CounterforceHealth.org.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan terms and clinical circumstances. Always consult with your healthcare provider and insurance plan for guidance specific to your situation. For assistance with insurance appeals in Texas, contact the Texas Department of Insurance at 1-800-252-3439.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.